As discussed above in Section 5.3, MMR deficiency testing of all Lynch-spectrum tumours to identify LS gene carriers had equivalent sensitivity to testing of CRCs and ECs. This evidence concerns the gene MRC1 and hyperinsulinemic hypoglycemia, familial, 4.